These Factsheets are restricted to ESMO Members, please login to see the list of drugs.
Last updated in 2012
5
-
5-Fluorouracil
-
- Category
- Antimetabolites
- Class
- Pyrimidine Analogues
9
-
90Y-Ibritumomab Tiuxetan
-
- Category
- B-cell Specific Monoclonal Antibodies
- Class
- Anti-CD20 Monoclonal Antibody
A
-
Abiraterone
-
- Category
- Hormonal Agents
- Class
- Antiandrogens
-
Actinomycin D
-
- Class
- Antibiotics
-
Afatinib
-
- Category
- Growth Factor Receptor Targeting Agents
- Class
- Dual Irreversible TKI of EGFR and HER2
-
Alemtuzumab
-
- Category
- B-cell Specific Monoclonal Antibodies
- Class
- Anti-CD52 Humanised Monoclonal Antibody
-
Amsacrine (m-AMSA)
-
- Category
- Topoisomerase-II Inhibitors
- Class
- Aminoacridines
-
Anagrelide
-
- Class
- Phosphodiesterase Inhibitors
-
Anastrozole
-
- Category
- Hormonal Agents
- Class
- Aromatase Inhibitors
-
Arsenic Trioxide
-
- Class
- Oxide of Arsenic
-
Axitinib
-
- Category
- Tumour Vessel Targeting Agents
- Class
- Tyrosine Kinase Inhibitor of VEGFR-1,2,3
-
Azacitidine
-
- Category
- Epigenetic Therapy
- Class
- DNA Methyltransferase Inhibitor
B
-
BCNU (Carmustine)
-
- Category
- Alkylating Agents
- Class
- Nitrosoureas
-
Bevacizumab
-
- Category
- Tumour Vessel Targeting Agents
- Class
- Anti-VEGF Recombinant Humanised Monoclonal Antibody
-
Bexarotene
-
- Class
- Retinoids
-
Bicalutamide
-
- Category
- Hormonal Agents
- Class
- Antiandrogens
-
Bleomycin
-
- Class
- Antibiotics
-
Brentuximab Vedotin (SGN-35)
-
- Category
- B-cell Specific Monoclonal Antibodies
- Class
- Anti-CD30 Antibody Drug Conjugate
-
Buserelin, Goserelin, Leuprorelin Acetate, Triptorelin
-
- Category
- Hormonal Agents
- Class
- Gonadotrophin Releasing Hormone (GnRH) Agonists
-
Busulfan
-
- Category
- Alkylating Agents
- Class
- Alkyl Sulfonates
C
-
Cabazitaxel
-
- Category
- Tubulin-active agents
- Class
- Taxane Formulations
-
Capecitabine (Xeloda)
-
- Category
- Antimetabolites
- Class
- Pyrimidine Analogues
-
Carboplatin
-
- Category
- Platinum Agents
- Class
- Platinum Analogues
-
CCNU
-
- Category
- Alkylating Agents
- Class
- Nitrosoureas
-
Cetuximab
-
- Category
- Growth Factor Receptor Targeting Agents
- Class
- Anti-EGFR Chimeric Monoclonal Antibody
-
Chlorambucil
-
- Category
- Alkylating Agents
- Class
- Nitrogen Mustards
-
Cisplatin
-
- Category
- Platinum Agents
- Class
- Platinum Analogues
-
Cladribine
-
- Category
- Antimetabolites
- Class
- Purine Analogues
-
Clofarabine
-
- Category
- Antimetabolites
- Class
- Purine Analogues
-
Crizotinib
-
- Category
- Cancer Related Receptors Targeting Agents
- Class
- Dual Inhibitor of MET and ALK
-
Cyclophosphamide
-
- Category
- Alkylating Agents
- Class
- Nitrogen Mustards
-
Cytarabine (Ara-C)
-
- Category
- Antimetabolites
- Class
- Pyrimidine Analogues
D
-
Dasatinib
-
- Category
- Cancer Related Receptors Targeting Agents
- Class
- Reversible Tyrosine Kinase Inhibitor of Bcr-Abl, KIT, PDGFR, SRC Family
-
Daunorubicin (DNR)
-
- Category
- Topoisomerase-II Inhibitors
- Class
- Anthracyclines
-
Decitabine
-
- Category
- Epigenetic Therapy
- Class
- DNA Methyltransferase Inhibitor
-
Degarelix
-
- Category
- Hormonal Agents
- Class
- Gonadotrophin Releasing Hormone (GnRH) Antagonists
-
Docetaxel
-
- Category
- Tubulin-active agents
- Class
- Taxane Formulations
-
Doxorubicin (DOX)
-
- Category
- Topoisomerase-II Inhibitors
- Class
- Anthracyclines
-
DTIC (Dacarbazine)
-
- Category
- Alkylating Agents
- Class
- Triazenes
E
-
Enzalutamide (MDV3100)
-
- Category
- Hormonal Agents
- Class
- Antiandrogens
-
Epirubicin (EPI)
-
- Category
- Topoisomerase-II Inhibitors
- Class
- Anthracyclines
-
Eribulin
-
- Category
- Tubulin-active agents
- Class
- Epothilones
-
Erlotinib
-
- Category
- Growth Factor Receptor Targeting Agents
- Class
- Reversible TKI of EGFR
-
Estramustine Phosphate
-
- Category
- Tubulin-active agents
- Class
- Epothilones
-
Etoposide (VP16)
-
- Category
- Topoisomerase-II Inhibitors
- Class
- Epipodophyllotoxins
-
Etoposide Phosphate
-
- Category
- Topoisomerase-II Inhibitors
- Class
- Epipodophyllotoxins
-
Everolimus
-
- Category
- Downstream Receptor Targeting Agents
- Class
- mTOR Inhibitor
-
Exemestane
-
- Category
- Hormonal Agents
- Class
- Aromatase Inhibitors
F
-
Fludarabine
-
- Category
- Antimetabolites
- Class
- Purine Analogues
-
Flutamide
-
- Category
- Hormonal Agents
- Class
- Antiandrogens
-
Fulvestrant
-
- Category
- Hormonal Agents
- Class
- ER Antagonist
G
-
Gefitinib
-
- Category
- Growth Factor Receptor Targeting Agents
- Class
- Reversible TKI of EGFR
-
Gemcitabine
-
- Category
- Antimetabolites
- Class
- Pyrimidine Analogues
H
-
Hydroxyurea
-
- Class
- Ribonucleotide Reductase Inhibitors
I
-
Idarubicin (IDA)
-
- Category
- Topoisomerase-II Inhibitors
- Class
- Anthracyclines
-
Idelalisib
-
- Category
- Downstream Receptor Targeting Agents
- Class
- PI3K Inhibitor
-
Ifosfamide
-
- Category
- Alkylating Agents
- Class
- Nitrogen Mustards
-
Imatinib
-
- Category
- Cancer Related Receptors Targeting Agents
- Class
- Reversible Tyrosine Kinase Inhibitor of Bcr-Abl, KIT, PDGFR
-
Interferon-α-2b/2a (IFN-α)
-
- Category
- Immunomodulatory Drugs and Cytokines
- Class
- Cytokines
-
Interleukin-2 (IL-2)
-
- Category
- Immunomodulatory Drugs and Cytokines
- Class
- Cytokines
-
Ipilimumab
-
- Category
- Immunomodulatory Drugs and Cytokines
- Class
- Anti-CTL4 Human Monoclonal Antibody
-
Irinotecan (CPT-11)
-
- Category
- Topoisomerase-I Inhibitors
- Class
- Camptothecins
-
Ixabepilone
-
- Category
- Tubulin-active agents
- Class
- Epothilones
L
-
L-asparaginase
-
- Class
- Enzymes
-
Lapatinib
-
- Category
- Growth Factor Receptor Targeting Agents
- Class
- Dual Reversible TKI of EGFR and HER2
-
Lenalidomide
-
- Category
- Tumour Vessel Targeting Agents
- Class
- Immunomodulatory Drugs
-
Letrozole
-
- Category
- Hormonal Agents
- Class
- Aromatase Inhibitors
-
Lexatumumab
-
- Category
- B-cell Specific Monoclonal Antibodies
- Class
- Anti-TRAIL-R2 Human Monoclonal Antibody
-
Liposomal doxorubicin (Doxil, Caelyx)
-
- Category
- Topoisomerase-II Inhibitors
- Class
- Anthracyclines
-
Liposomal doxorubicin (Myocet)
-
- Category
- Topoisomerase-II Inhibitors
- Class
- Anthracyclines
M
-
Mapatumumab
-
- Category
- B-cell Specific Monoclonal Antibodies
- Class
- Anti-TRAIL-R1 Human Monoclonal Antibody
-
Medroxyprogesterone Acetate
-
- Category
- Hormonal Agents
- Class
- Progestins
-
Megestrol Acetate
-
- Category
- Hormonal Agents
- Class
- Progestins
-
Melphalan
-
- Category
- Alkylating Agents
- Class
- Nitrogen Mustards
-
Methotrexate (MTX)
-
- Category
- Antimetabolites
- Class
- Antifolates
-
Mitomycin C
-
- Class
- Antibiotics
-
Mitoxantrone (dihydroanthracenedione; DHAD)
-
- Category
- Topoisomerase-II Inhibitors
- Class
- Anthracenediones
N
-
Nab-paclitaxel
-
- Category
- Tubulin-active agents
- Class
- New Taxane Formulations
-
Neratinib
-
- Category
- Growth Factor Receptor Targeting Agents
- Class
- Irreversible Pan-HER Tyrosine Kinase Inhibitor
-
Nilotinib
-
- Category
- Cancer Related Receptors Targeting Agents
- Class
- Reversible Tyrosine Kinase Inhibitor of Bcr-Abl, KIT, PDGFR
-
Nilutamide
-
- Category
- Hormonal Agents
- Class
- Antiandrogens
-
Nimotuzumab
-
- Category
- Growth Factor Receptor Targeting Agents
- Class
- Anti-EGFR Humanised Monoclonal Antibody
O
-
Obinutuzumab
-
- Category
- B-cell Specific Monoclonal Antibodies
- Class
- Anti-CD20 Humanised Monoclonal Antibody
-
Ofatumumab
-
- Category
- B-cell Specific Monoclonal Antibodies
- Class
- Anti-CD20 Human Monoclonal Antibody
-
Onartuzumab
-
- Category
- Cancer Related Receptors Targeting Agents
- Class
- Monoclonal Antibody Inhibiting the Binding of HGF to MET Receptor
-
Oxaliplatin
-
- Category
- Platinum Agents
- Class
- Platinum Analogues
P
-
Paclitaxel
-
- Category
- Tubulin-active agents
- Class
- Taxane Formulations
-
Panitumumab
-
- Category
- Growth Factor Receptor Targeting Agents
- Class
- Anti-EGFR Humanised Monoclonal Antibody
-
Pazopanib
-
- Category
- Tumour Vessel Targeting Agents
- Class
- Tyrosine Kinase Inhibitor of VEGFR-1,23, PDGFR-α and PDGFR-β, KIT
-
Pemetrexed
-
- Category
- Antimetabolites
- Class
- Antifolates
-
Pertuzumab
-
- Category
- Growth Factor Receptor Targeting Agents
- Class
- Anti-HER2 Humanised Monoclonal Antibody
-
Procarbazine
-
- Category
- Alkylating Agents
R
-
Rituximab
-
- Category
- B-cell Specific Monoclonal Antibodies
- Class
- Anti-CD20 Chimeric Monoclonal Antibody
-
Romidepsin
-
- Category
- Epigenetic Therapy
- Class
- Histone Deacetylase Inhibitor
S
-
Sorafenib
-
- Category
- Tumour Vessel Targeting Agents
- Class
- Tyrosine Kinase Inhibitor of BRAF, CRAF, KIT, Flt-3, RET, VEGFR, and PDGFR-β
-
Sunitinib
-
- Category
- Tumour Vessel Targeting Agents
- Class
- Tyrosine Kinase Inhibitor of PDGFR-α and PDGFR-β, VEGFR-1,2,3, KIT and RET
T
-
Tamoxifen
-
- Category
- Hormonal Agents
- Class
- Selective Oestrogen Receptor Modulators
-
Temozolomide
-
- Category
- Alkylating Agents
- Class
- Triazenes
-
Temsirolimus
-
- Category
- Downstream Receptor Targeting Agents
- Class
- mTOR Inhibitor
-
Teniposide (VM26)
-
- Category
- Topoisomerase-II Inhibitors
- Class
- Epipodophyllotoxins
-
Thalidomide
-
- Category
- Tumour Vessel Targeting Agents
- Class
- Immunomodulatory Drugs
-
Thio-TEPA
-
- Category
- Alkylating Agents
- Class
- Aziridines (Ethylenimines)
-
Thiopurines: 6-mercaptopurine (6-MP), Thiopurines: 6-Thioguanine (6-TG)
-
- Category
- Antimetabolites
- Class
- Purine Analogues
-
Tivantinib
-
- Category
- Cancer Related Receptors Targeting Agents
- Class
- MET Inhibitor
-
Topotecan
-
- Category
- Topoisomerase-I Inhibitors
- Class
- Camptothecins
-
Toremifene
-
- Category
- Hormonal Agents
- Class
- Selective Oestrogen Receptor Modulators
-
Trabectedin
-
- Class
- Marine Derivatives
-
Trastuzumab
-
- Category
- Growth Factor Receptor Targeting Agents
- Class
- Anti-HER2 Humanised Monoclonal Antibody
-
Tretinoin (all-trans-retinoic acid, ATRA)
-
- Class
- Retinoids
V
-
Vemurafenib
-
- Category
- Downstream Receptor Targeting Agents
- Class
- BRAF V600E Inhibitor
-
Vinblastine
-
- Category
- Tubulin-active agents
- Class
- Vinca Alkoloids
-
Vincristine
-
- Category
- Tubulin-active agents
- Class
- Vinca Alkoloids
-
Vinflunine
-
- Category
- Tubulin-active agents
- Class
- Vinca Alkoloids
-
Vinorelbine
-
- Category
- Tubulin-active agents
- Class
- Vinca Alkoloids
-
Vorinostat
-
- Category
- Epigenetic Therapy
- Class
- Histone Deacetylase Inhibitor